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ABSTRACT 
Aim 
To explore the practice of nurses who prescribe medication for patients with skin conditions. 
 
Background 
Nurses have lead roles dermatology services. In the United Kingdom nurses in primary care 
frequently prescribe medicines for skin conditions, but there are concerns about role 
preparation and access to continuing professional development. The prescribing practices of 
nurse independent supplementary prescribers who care for patients with skin conditions are 
under researched.  
 
Design: Cross-sectional survey 
 
Methods: An online questionnaire was used to survey 186 nurses who prescribed for skin 
conditions May-July 2010. Data were analysed using descriptive statistics and non-
parametric tests. 
 
Results 
The majority worked in primary care (78%), and general practice (111, 59.7%). Twenty 
(10.8%) had specialist-modules (at diploma, degree or masters level), 104 (55.9%) 
dermatology training (e.g. study days), 44 (23.7%) no training, and a further 18 (9.6%) did 
not respond. Oral-antibiotics, topical anti-fungal and anti-bacterial were frequently 
prescribed. Nurses with specialist-dermatology training used their qualification in a greater 
number of ways, prescribed the broadest range of products, and prescribed more items per 
week. Over 70% reporting on continuing professional development had been able to access it. 
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Conclusion  
Large numbers of nurses in primary care prescribe medicines for skin conditions and are 
involved in medicines management activities. Lack of specialist dermatology training is a 
concern and associated with lower prescribing-related activities. Access to dermatology 
training and continuing professional development is required to support nurse development in 
this area of practice and maximise benefits. 
 
Relevance to clinical practice 
Nurse prescribers’ involvement in medicines management activities has important 
implications in terms of improving access to services, efficiency and cost savings. In order to 
maximise their contribution, improved provision of specialist dermatology training is 
required. This will be of interest to education providers and service planners in the United 
Kingdom, and countries around the world. 
 
 
Key-words skin, nurse prescribing, medicines-management-activities, survey 
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Introduction 
Over a quarter of the population has a skin problem (e.g. eczema, leg ulcers and skin cancer) 
that can benefit from medical care at any one time (Schofield et al. 2009). Every year around 
12.9 million people in the United Kingdom (UK) consult a doctor regarding a skin related 
condition, 6% of whom are later seen within the specialist dermatology service (DH 2007, 
Schofield et al. 2009). While it is recognised that large numbers of people manage their own 
condition, the demand for skin related appointments in the UK is high (All Party 
Parliamentary Group on Skin 2004, British Association of Dermatologists & Royal College 
of Physicians 2008), each general practitioner (GP) having on average 12 skin related 
consultations per week (DH 2007, Schofield et al. 2009).   
 
The provision of health services which are both flexible and accessible to patients is a key 
government priority in the UK (DH 1999b,  2000,  2007). However, the demand for skin 
related appointments means that doctors are increasingly unable to meet the service demands 
(All Party Parliamentary Group on Skin 2004, British Association of Dermatologists & Royal 
College of Physicians 2008). It is recognized that nurses have lead roles to play in the 
delivery of dermatology services (Cox & Walton 1998, DH 2007, McEvoy 2004) and that 
nurse-led care enhances the care that patients with dermatology conditions receive (Moore et 
al. 2009, Schuttelaar et al. 2009, van Os-Medendorp et al. 2007). Dermatology conditions are 
amongst the most frequently presented problems in immediate-access settings (such as walk-
in centres and out-of hours) (Kinnersley et al. 2000, Salisbury & Munro 2002). These 
services, designed to improve access to frontline healthcare, are predominantly provided by 
nurses. In order that the skills of these healthcare professionals are optimised, and patients are 
able to access medicines faster, many of these nurses in the UK are qualified to prescribe. 
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Nurse prescribing has been introduced in a number of countries (e.g. the United States, 
Australia, Ireland, and Botswana), as a means to improve efficiency and access to treatment 
(Ball 2009, Kroezen et al. 2011, Miles et al. 2006). There is however, considerable variation 
between the policies and practice of each country. For example, in the United States where 
advanced practice registered nurses (APRN) are able to prescribe, prescriptive authority 
across the 50 states varies with regards to requirements, standards and practices (Buchan & 
Calman 2004).  
 
In the UK, following a series of legislative changes between 1992 and 2006, nurses have 
virtually the same prescribing rights as doctors (DH 2002,  2006). Community practitioners 
(CP), of which there are approximately 32,000, were the first group to be provided with  the 
capacity to prescribe from a restricted formulary (mainly over the counter products/medicines 
and wound dressings) listed in the Nurse Prescribers Formulary for Community Practitioners 
(Nursing and Midwfery Council (NMC) 2011). Independent prescribing rights were extended 
in 2001 to include other groups of registered nurses (DH 2002). Nurse Independent 
Prescribing (NIP) and Nurse Supplementary Prescribing (NSP) are two additional forms of 
prescribing. Through NIP, nurses may assess, diagnose and prescribe independently any 
licensed or unlicensed medicine with the exception of some controlled drugs for the treatment 
of addiction (DH 2006, Home Office 2012, Medicines and Healthcare products Regulatory 
Agency (MHRA) 2009). By contrast, NSP is a form of dependent prescribing where the 
initial diagnosis is made by a doctor and a Clinical Management Plan (CMP) detailing the 
medicines that can be prescribed, must be agreed between the NSP, doctor and patient (DH 
2003). 
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Importantly, prior to legislative change in 2006 nurses using NIP could only prescribe a 
limited range of products from the Nurse Prescribers Extended Formulary. This formulary 
included a list of nearly 250 Prescription Only Medicines (POM), General Sales List (GSL) 
items and Pharmacy (P) medicines for a range of over 100 medical conditions, a significant 
category of which was skin conditions. There are now over 23,000 nurses (qualified as 
independent and supplementary prescribers (NISPs)) (NMC 2011) with the most extended 
prescribing rights in the world.  
 
It is recognised that approximately a third of NISPs, the majority of whom are based in 
primary care and work in general practice, contribute to the provision of services for patients 
with skin conditions (Courtenay & Gordon 2009, Latter et al. 2010) and that prescribing 
enhances the care they provide (Carey et al. 2010, Courtenay et al. 2009a, Courtenay et al. 
2011b). Improved access to medicines, better use of health professionals’ skills, and 
increased flexible working are all benefits associated with dermatology nurse prescribing 
(Carey et al. 2010, Courtenay et al. 2009a, Courtenay et al. 2011b). Patients additionally 
report that they like the continuity of care, comprehensive information and holistic care that 
they receive from nurse prescribers for their skin conditions (Courtenay et al. 2011). 
However, since legislative changes in 2006 (DH 2006), there is no research available that has 
explored the profile and prescribing practices of these nurses. This is important given that this 
legislation enabled nurses to independently prescribe any medicine for any skin condition 
within their area of competence.  
 
Background 
Findings from two recent UK surveys designed to explore the therapy areas in which nurses 
prescribe and the settings in which they work, identified that the majority of nurses who 
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prescribe for dermatology patients are based in primary care and are employed in general 
practice (Courtenay & Gordon 2009, Latter et al. 2010). While there is some evidence from 
the United States that APRNs practicing in dermatology frequently prescribe (Goolsby 2005), 
international evidence regarding the profile and prescribing practices of nurses who care for 
patients with skin conditions is lacking (Ball 2009, Kroezen et al. 2011). 
 
Only one study, conducted in 2005 (Courtenay et al. 2006), has specifically reported on the 
prescribing practices of nurses who care for dermatology patients. In this study, Courtenay et 
al. (2006) found 75% of the 868 independent extended and supplementary prescribers 
surveyed prescribed for dermatology patients, 90% worked in primary care and 58% were 
based in general practice. Examination of the dermatology prescribing practices of these 
nurses indicated that over a third prescribed 1-5 items a week, and products most frequently 
prescribed were for the management of fungal infections, atopic dermatitis and impetigo 
(Courtenay et al. 2007a). Although nearly all respondents used their prescribing qualification 
(95% as an NIP and 37% as a NSP), nurses with specialist dermatology training (i.e. a 
diploma, degree, or masters level module in dermatology, or dermatology study days) 
prescribed more frequently, and for a broader range of skin conditions. Constraints caused by 
local arrangements (e.g. waiting for prescription pads and a lack of prescribing budget), a 
lack of understanding and support, difficulties implementing the CMP and a lack of access to 
continuing professional development (CPD) were reported to be factors that restricted nurses’ 
prescribing practice (Carey & Courtenay 2007, Courtenay et al. 2007a). 
 
Although nurses in general are positive about the adoption of the role as prescriber (Latter et 
al. 2010) there are ongoing concerns surrounding preparation (Bradley et al. 2006, Latter et 
al. 2005, Otway 2001, Rana et al. 2009 , Sodha et al. 2002), support for the role (Humphries 
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& Green 2000, Stenner & Courtenay 2008), and access to CPD (Courtenay & Gordon 2009, 
Humphries & Green 2000, Luker & McHugh 2002).  
 
Despite these concerns, recent evidence suggests that undertaking the prescribing 
qualification has a wider impact on nurse’s practice than purely the issuing of prescriptions. 
Although not specifically looking at dermatology services, nurses who have adopted the 
prescribing role in other areas of practice report that their involvement in medicines 
management activities, such as amending prescribed medication (i.e. alter, stop or correct 
dosage), medication review, and remote prescribing (via telephone, fax, or email) (Carey et 
al. 2009, Courtenay et al. 2009b, Stenner & Courtenay 2008), has increased. For example, 
specialist pain nurses (n=26) interviewed by Stenner and Courtenay (2008) believed that 
clinically inappropriate prescribing in the area of pain management was avoided or corrected 
by specialist nurses adopting the prescribing role. Similarly, children’s nurses (n=7) 
interviewed by Carey et al. (2009) reported that having the capacity to prescribe allowed 
them to avert and / or correct medication errors. However, the extent to which nurses who 
prescribe for dermatology conditions are involved in these medicines management activities 
has not yet been explored. 
 
Evidence examining how legislative changes since 2006 (enabling nurses to prescribe any 
medicine for any dermatology condition) have impacted on prescribing practices, role 
preparation and CPD needs is lacking. This is important as this information will help us 
understand how NISP is used in service delivery and the support required for this role. 
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The study 
 
Aim 
To explore the practice of nurses who prescribe medication for patients with skin conditions. 
 
Design 
A cross-sectional survey was adopted, using an on-line questionnaire. This paper reports on 
questionnaire data that formed part of larger survey designed to evaluate NISP in the UK, the 
results of which are reported elsewhere (Courtenay et al. 2010). Data were collected between 
May-July 2010. 
 
Participants 
The participants were a convenience sample of 186 nurses located throughout the UK. All 
were qualified as either NISPs or CPs and registered on the Association for Nurse Prescribing 
(ANP) membership database. All prescribed medicines for dermatological conditions. 
Membership of the ANP, an independent organization that provides support and education 
for nurses in their role as a prescriber, is optional and thus provided a convenient point of 
access to NPs in the UK.  
 
Questionnaire 
The questionnaire was disseminated using Survey Monkey© an internet-based survey tool. 
The questionnaire comprised of four sections and used both closed and open-ended questions. 
Simple instructions on how to complete it were provided. The first section of the 
questionnaire collected general demographic information including job title, geographical 
area, care setting, type of services provided, the number of nurse prescribers (NP) in the 
10 
 
team, and future plans for NPs in their area of practice. The second section asked respondents 
about their prescribing practice including type of prescribing qualification, years qualified as 
a prescriber, level of experience, and method of prescribing.  
 
At the end of the second section, participants who prescribed medicines for dermatology 
conditions were invited to complete a number of further questions regarding their specialist 
training in dermatology, the number of items prescribed for dermatology conditions per 
week, the ways in which they used their prescribing qualification, which 
conditions/medicines they prescribed, the source(s) of evidence used to inform their 
prescribing decisions, whether they had access to CPD, if they had undertaken CPD, their  
three most urgent CPD needs and preferred method of learning. Tick, and / or free-text, boxes 
were provided for responses.  
 
Data collection 
All NPs registered on the ANP membership database (n=859) with a valid email address, 
were sent an email invitation, by the ANP administrator, to participate in the on-line survey.  
This large sample was required to ensure that each one of the broad range of settings in which 
nurses prescribe medicines for patients was represented. Based on the findings and response 
rates of previous national surveys undertaken by the researchers (Courtenay et al. 2006, 
Courtenay & Gordon 2009), it was estimated that a 65% response rate would be achieved, of 
whom 40% of respondents would prescribe medicines for patients with dermatology 
conditions.  
The invitation email outlined the purpose of the study and what would be required of them. 
Assurance was given that respondents would remain anonymous and that participation was 
entirely voluntary. Those who wished to participate were asked to use an electronic link 
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within the email to access the on-line survey. After three email reminders, 439 (51.1%) valid 
responses were received, of which 186 (42.2%) reported they prescribed for dermatological 
conditions.  
 
Ethical approval 
University ethical approval for the study was obtained. 
 
Data Analysis 
Microsoft Excel and SPSS version 17 were used for data entry and analysis. Some 
respondents did not complete every item on the questionnaire. Initial exploration showed that 
respondents were inconsistent in the extent to which they completed the questionnaire. Due to 
the sample size it was not feasible to remove responses from participants who did not 
complete every item. Consequently there is some fluctuation in the number of respondents 
reported in the different aspects of the survey and in the data presented in the supporting 
tables. The number of respondent’s providing data for different aspects of the questionnaire is 
presented within each section of the results, and described under the relevant tables. 
 
Descriptive statistics were used to describe the demographic nature of the sample. Non-
parametric tests were used pragmatically to explore the differences between variables e.g. job 
title, care setting, specialist dermatology module, dermatology training and education, 
number of items prescribed per week, number of dermatology products prescribed, and 
methods of using the prescribing qualification. These procedures, and variables were based 
on previous surveys that have explored the prescribing practices of NISPs (Courtenay et al. 
2006, Courtenay & Gordon 2009). Where two groups are compared for an ordinal response 
(e.g. number of items prescribed per week, number of dermatology products prescribed, and 
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methods of using the prescribing qualification) Mann-Whitney U test is used. Where three or 
more groups are compared for an ordinal response, (e.g. dermatology training, job title, care 
setting and  number of ways the prescribing qualification is used) the Kruskal Wallis test is 
used (Field 2005, Pallant 2005). In order to counteract the problem of multiple comparisons, 
and increased risk of Type 1 error, a Bonferroni correction of the alpha level was applied 
Five multiple tests were performed, and the level of significance was adjusted from p=0.05 to 
p=0.01) (Field 2005). Content analysis, the systematic process of organizing free text 
comments into emerging themes with the goal of quantitatively measuring variables (Parahoo 
2006), was used to analyse free text comments which were independently reviewed by a 
second researcher.  
 
Reliability and validity 
Where possible, the content and format of the questions were similar to those used in 
previous surveys of NP in the UK in order to increase reliability and enable comparison with 
earlier work (Carey et al. 2007, Courtenay & Carey 2006, Courtenay et al. 2007a). Piloting 
the questionnaire prior to dissemination on six nurses who prescribed for dermatological 
conditions was used to achieve face validity of the questionnaire (Parahoo 2006). They were 
asked to comment on the classification of dermatology products prescribed, and methods of 
using the prescribing qualification for patients with dermatology conditions. Each nurse was 
asked to comment on the appropriateness on the content, ease of completion, and any 
difficulties experienced completing it. Based on these comments minor refinements were 
made to the wording of a couple questions. 
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Results 
Demographic details 
The majority of respondents were based in primary care (145, 78.0%) and worked as GP 
nurses (111, 59.7%) (see table 1). Twenty (10.8%) had undertaken a specialist dermatology 
module (at diploma, degree or masters level). However, most (104, 55.9%) had only 
undertaken study days (including those supported by the pharmaceutical industry), 44 
(23.7%) had not undertaken any specialist dermatology training and a further 18 (9.6%) did 
not respond to this question.  
 
Service provision 
Participants were from all regions of England, Scotland and Wales, with 23.1% (n=43) based 
in South-East England (see table 1). While the majority provided a GP service (117, 62.9%), 
nurses also reported they were involved in a range of other services including the community 
(27, 14.5%), out of hours (25, 13.4%), hospital out-patient (23, 12.4%), walk-in-centre (22, 
11.8%), hospital in-patient (15, 8.1%), community clinic (12, 6.5%), education/ research (10, 
5.4%) and other services (i.e. independent sector, prison, armed forces) (8, 4.3%). 
 
The majority (108, 58%) of respondents reported that there was more than one NP in their 
team (mean=2.85) (see table 1). Seventy one (38.2%) reported one nurse prescriber in their 
team, and 9 (4.8%) more than ten. Plans to increase the number of NPs were reported by 71 
(38.2%) participants, and 35 (18.8%) reported that a team member was currently undertaking 
prescribing training.  
 
Prescribing Practice 
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One hundred and eighty-three (98.4%) participants reported they prescribed independently, 
and two used supplementary prescribing (1.1%) (see table 1). Of the 151 participants who 
reported on the number of items they independently prescribed for dermatological conditions 
in a week the majority (n=83, 54.9%) prescribed 1-5 items. Using the Kruskal Wallis Test it 
was evident that compared to other groups of nurses GP nurses prescribed the greatest 
number of items per week (p=0.003), with 30% prescribing more than 6 items a week (see 
table 2). Further analysis using the Mann-Whitney U test found nurses who had undertaken 
training (accredited study days or otherwise) also prescribed significantly more items per 
week than those who had not (p<0.001) (see table 3).  
 
Participants used a number of sources of evidence to inform their practice including the 
British National Formulary (n=145, 78.0%), National Institute of Clinical Excellence (NICE) 
guidelines (n=126, 67.7%), local guidelines (n=111, 59.7%), clinical knowledge summaries  
(n=97, 52.2%), journals and bulletins (n=88, 47.3%), and other national guidance (n=51, 
27.4%).  
 
Dermatology products which nurses independently prescribe 
The range of dermatology products participants prescribed is shown in figure 1. Using 
Kruskal Wallis it was evident that GP nurses prescribed a significantly wider range of 
products than nurses with other job titles (p<0.001) (see table 4). Similarly, nurses who 
worked in primary care prescribed for a significantly broader range of products than those in 
other care settings (p=0.003). Further analysis (using Mann-Whitney U identified that nurses 
with specialist training (accredited study days or otherwise) prescribed a wider range of 
products than those without (p=0.015). The range of products prescribed was 0-19, mean= 
9.12, SD=4.36 and median =9. 
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Methods of using the prescribing qualification 
One hundred and fifty six (83.8%) participants reported on the methods of using the 
prescribing qualification. Participants reported that they used the prescribing qualification in 
a variety of ways (see figure 2). Of these respondents 129 (82.7%) reported that they issued 
FP10 prescriptions directly to patients (FP10 prescription forms are purchased by each Trust 
for prescribing medication that is to be dispensed by community pharmacies in the UK), 119 
(76.3%) amended prescribed medication (i.e. alter, stop or correct dosage) and 105 (67.3%) 
were involved in medication review. One hundred and forty two (91.0%) reported that they 
recommended patients buy medicine(s) over the counter whereas only 17 (10.8%) issued 
private prescriptions. The range of methods by which the prescribing qualification was 
used=0-8, mean=3.47, SD=2.05, mode=5. 
 
Analysis using the Mann-Whitney U test identified that nurses with specialist training 
(p=0.002), or a dermatology module (p=0.007) used their prescribing qualification in a 
significantly greater number of ways than those without. Analysis using the Kruskal Wallis 
test also identified that GP nurses and those who worked in primary care used their 
prescribing qualification in a greater number of ways than other types of nurses and those in 
other care settings, but this was not to a level of statistical significance (p>0.05 (see table 5)). 
 
Continuing professional development 
One hundred and thirty three (71.5%) reported on aspects of the questionnaire exploring 
access and availability of CPD. Of these respondents ninety six (72.2 %) indicated they had 
access to, and had undertaken CPD to support them in their prescribing practice for 
dermatology patients and 37 (27.8%) indicated they had not. Forty one (30.8%) reported 
difficulties fulfilling their dermatological CPD needs. Difficulties identified from free text 
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comments included a lack of appropriate CPD (n=19) and issues over access, availability and 
time to undertake CPD (n=16). The areas for which respondents (n=102) had the most urgent 
CPD needs were the assessment and diagnosis of skin conditions (64%, n=65), psoriasis 
(42%, n=43) and acne (32%, n=33). 
 
Participants (186) were also asked to indicated their preferred method of accessing CPD: 94 
(50.5%) reported e-learning while action learning sets (i.e. facilitated small groups that meet 
regularly to provide support and act on work issues) (10, 7.5%) were the least preferred 
method. Ninety (48.4%) indicated a preference for journals, and 88 (47.3%) formal study 
days. Prescribing forums, individual study and non-accredited lunch-time or evening sessions 
were each reported to be the preferred method of accessing CPD by 52 (28%) participants. 
Smaller numbers preferred work-based learning (50, 26.9%), non-medical prescribing 
conferences (43, 23.1%), and clinical speciality conferences (17, 9.1%). 
 
Discussion 
Limitations 
We acknowledge that NPs who become members of the ANP are likely to be actively 
prescribing and keen to access support and education; therefore, their views may not be 
reflective of all nurse prescribers. The limitations of using face validity is also acknowledged, 
and the need for further surveys in this area of practice to include more robust measures of 
reliability and validity. Limitations of the data set resulted in the pragmatic use of non-
parametric tests to explore the differences between demographic variables, and increased risk 
of type 1 error. Although a Bonferroni correction of the alpha level was applied, a further 
study, sufficiently powered to the test the hypothesis should be carried out to confirm the 
findings. Despite this, and the relatively small sample size in proportion to the number of 
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qualified nurse prescribers, the demographic nature of the sample is similar to previous 
surveys which have explored nurse prescribing in the UK (Courtenay et al. 2007a, Courtenay 
& Gordon 2009, Latter et al. 2010). It therefore provides an important update of how NISP is 
currently being used to provide services to patients with dermatological conditions. 
 
Discussion of results 
This is the first study, since 2006 and 2009 legislative changes (DH 2006, MHRA 2009) to 
explore the practice of NISPs who prescribe medicines for patients with dermatological 
conditions. Our study provides empirical evidence that UK nurses based in primary care, and 
working in a variety of practice settings, use the NISP qualification to provide care to patients 
with a broad range of skin conditions.  
 
In-line with previous surveys of nurse prescribing (Courtenay et al. 2007a, Courtenay & 
Gordon 2009, Latter et al. 2010), the majority of nurses in our sample were based in primary 
care, worked in general practice and had more than 5 years experience as a prescriber. 
Additionally, the findings provide some evidence that although NPs are working across all 
parts of the UK, the majority prescribing for skin conditions appear to be based in South-East 
England.  
 
The large percentage of nurses who reported that they provide services in primary care i.e. 
general practice, community and immediate-access settings (such as walk-in centres and out-
of hours) highlights the important contribution that nurse prescribing can make across a range 
of practice settings in which dermatology patients are treated. This is in line with the 
anticipated benefits of recent UK government policy (DH 2000,  2006,  2007), a key 
component of which has been to provide convenient and flexible access to healthcare (DH 
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1999a,  2000) and to deliver services closer to patients homes (DH 2007). It is also consistent 
with the development of nurse prescribing policy in a number of other countries, particularly 
those with lower-incomes such as Botswana and South Africa, which has evolved as part of 
the strategy designed to provide equitable access to safe and affordable medicine to people 
around the world (Bhanbhro et al. 2011, Miles et al. 2006). 
 
Regardless of nurse’s role, products frequently prescribed by participants in this survey were 
for the treatment of bacterial and fungal skin infections (i.e. oral antibiotics, topical anti-
fungal and topical anti-bacterial). Whilst we acknowledge that these type of infections may 
sometimes require long term and / or systemic treatment, our results are in-line with recent 
evidence from the US that topical anti-infective products and topical hydrocortisone are the 
most commonly used over the counter products for dermatology conditions (Nolan et al. 
2012). In addition to being managed by GPs (Royal College of General Practitioners 
Birmingham Research Unit 2006), skin infections of all types (i.e. bacterial, fungal and viral), 
the majority of which require only a one-off episode of care, were those most frequently 
reported to be managed by dermatology nurse prescribers (Courtenay et al. 2007a), and 
observed in video-consultations of their practice (Courteany et al. 2009). Our findings 
therefore present further evidence to suggest that independent prescribing is predominantly 
used to provide treatments to this group of patients. 
 
Our results indicate a decline in the use of NSP since 2005. This is in line with findings from 
a national evaluation of nurse and pharmacist independent prescribing, only 17.6% of NISPs 
surveyed in 2008 used supplementary prescribing in their practice (Latter et al. 2010). 
Supplementary prescribing was primarily intended for use in managing chronic and long-
term conditions including chronic skin disease (DH 2003). Using NSP, medicines can only be 
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prescribed once an initial diagnosis has been made by a doctor and a CMP detailing the 
medicines has agreed between the NSP, doctor and patient.  However, nearly 80% of 
respondents provided services in primary care i.e. general practice, community and 
immediate-access settings (such as walk-in centres and out-of hours). It is reasonable to 
speculate that NSP is not appropriate for the management of skin conditions which 
predominantly require only one-off treatments accessed via these services for which nurses 
can now independently prescribe. Previous research has indicated that NSP remains useful 
where nurses lack confidence, or where this is the only mode of prescribing supported by an 
organization (Courtenay et al. 2011a).  
 
In line with previous findings (Carey et al. 2007, Courtenay et al. 2007a), GP nurses 
prescribed the highest number of items (the majority prescribing 1-5 items in a typical week) 
and the widest range of products. Interestingly, GP nurses in Courtenay et al.s ‘ (2007a) work 
reported a slightly higher prescribing rate i.e. between 6-10 dermatological products each 
week. This possibly reflects that some patients now access medicines for their dermatology 
conditions through immediate access settings (such as walk-in centres) as opposed to their 
GP. However, in order to fully understand this finding, further investigation is required.  
 
Respondents used the prescribing qualification in a variety of ways. While the majority 
reported they issued prescriptions directly to the patient, over three quarters of the sample 
reported that they used their qualification to amend prescriptions and were involved in 
medication review. At the time of study there were some qualitative reports (Carey et al. 
2009, Stenner & Courtenay 2008) that NPs were taking a more active role in other medicine 
management activities as opposed to prescribing. However, recent survey findings from 883 
non-medical prescribers across a large geographical area (Courtenay et al. 2012), provides 
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detailed evidence that NPs are engaged in a range of activities  that can also impact on the 
service efficiency, quality of care and patient outcomes. Nevertheless, this is the first study to 
confirm the breadth of these activities and extent to which NPs undertake them for patients 
with dermatology conditions. It is however; acknowledged that further more detailed 
exploration of the situations where nurses alter, stop or correct dosage for patients with 
dermatology conditions is also required. The diverse range of medicines management 
activities in which NPs are involved needs to be recognised by those responsible in service 
planning. Not only do NPs provide an opportunity to overcome some of the demands on 
appointments for doctors (All Party Parliamentary Group on Skin 2004, British Association 
of Dermatologists & Royal College of Physicians 2008), and improve quality of care (NPSA 
2007), they also have important implications for potential cost savings. Given the large 
number of people who seek medical care for skin related conditions (Schofield  et al. 2009) 
and the lack of international evidence regarding dermatology nurse prescribing (Ball 2009, 
Kroezen et al. 2011), our findings suggest investigation of the profile and prescribing 
practices of nurses who care for this group of patients in other countries is urgently required. 
 
Nearly a quarter of participants in our sample indicated that they had never undertaken any 
specialist dermatology training. This supports previous concerns about the inadequate levels 
of training and knowledge that nurses have in the management of skin problems (All Party 
Parliamentary Group on Skin 2004, Courtenay et al. 2007a, Ersser et al. 2005, Ogden et al. 
2006, Schofield et al. 2009). Nurses in our study with specialist dermatology training 
prescribed more frequently and used their prescribing qualification in a greater number of 
ways, therefore emphasising the importance of dermatology training with regards to 
maximising nurse’s contribution to general dermatology services. By implication, the skin 
care services offered by nurse prescribers could be extended if it was ensured that those 
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nurses who accessed prescribing training and treated dermatology patients had specialist 
training. Our findings reinforce NMC guidance (NMC 2006) which stipulates that nurses 
need to acquire specialist knowledge prior to undertaking the prescribing programme. The 
need to ensure that NPs have specialist knowledge is also reinforced by recent evidence from 
dermatology patient interviews (Courtenay et al. 2011b). Although patients had few concerns 
about nurse prescribing, adequate training and specialist knowledge were seen as essential by 
nurses adopting this role (Courtenay et al. 2011b). Given that there is increasing international 
recognition of the importance that nursing can make to the provision of dermatology services 
worldwide (Ersser et al. 2011), our findings highlight the ongoing need for agreed levels of 
training in this area of practice (All Party Parliamentary Group on Skin 2004, Schofield et al. 
2009).  
 
Over 70% of the participants in our study reported they had accessed CPD to support their 
current prescribing role. This is higher than the 60% reported previously (Courtenay et al. 
2007b). Although this suggests that there has been some improvement with regards to 
accessing dermatology CPD, CPD needs were reported for conditions which participants less 
frequently prescribed (including psoriasis, and acne). While this may therefore reflect that 
non-specialist nurses see patients with chronic skin conditions, it is possible that it also 
reflects that nurses recognise they need to undertake CPD in order to prescribe for these 
conditions. Although participants reported a number of ways they would like to access CPD, 
e-learning, as previously reported (Courtenay & Gordon 2009), was their preferred method of 
learning.  
 
Conclusion 
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In the UK large numbers of nurses in primary care prescribe medicines for skin conditions. 
These nurses also use their prescribing qualification to support their involvement in other 
medicines management activities. This has important implications for improving access to 
services, increased efficiency and cost savings and will be of interest to those involved in 
service planning in the UK and other countries around the world. However, lack of specialist 
dermatology training is a concern. A lack of specialist training is associated with lower rates 
of prescribing and a reduction in the number of ways in which nurses use the prescribing 
qualification. Access to dermatology training and continuing professional development is 
required to support nurse development in this area of practice and to maximise benefits. 
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Table 1: Demographic Details 
 
 
 
 
 
 
 
 
 
 
 
             n=number of 
responses 
% of total sample 
Job Title  
General practice nurses (practice nurses and nurse practitioners) 111 59.7 
Specialist & senior clinical nurses  (clinical nurse specialists, nurse consultant, 
specialist nurse practitioners, modern matron, mental health nurse) 
56 30.1 
Community Nurses  (community matron, health visitor, district nurse, school nurse) 11 5.9 
Higher education & managers 5 2.7 
Geographical location  
Scotland 18 9.7 
Wales 6 3.2 
Northern England 6 3.2 
Yorkshire & Humber 10 5.4 
North West England 18 9.7 
Eastern England 17 9.1 
London 23 12.4 
South West England  21 11.3 
South East England 43 23.1 
East Midlands 8 4.3 
West Midlands 16 8.6 
Care setting  
Primary care 145 78.0 
Secondary Care 23 12.4 
Primary and Secondary Care 9 4.8 
Mental Health 4 2.2 
Other settings (higher education, intermediate care) 5 2.7 
Prescribing qualification   
Nurse Independent Supplementary Prescriber(NISP) 183 98.4 
Community Practitioner Prescriber (CP)   3 1.6 
Years qualified as a prescriber   
< 1 year 11 5.9 
1-3 years 36 19.4 
3-5 years 62 33.3 
> 5 years 76 40.9 
Experience in area of practice before becoming prescriber   
< 1 year 5 2.7 
1-2 years 10 5.4 
2-5 years 36 19.4 
> 5 years 132 71.0 
Dermatology training and education (more than one response could be given)   
Diploma, Degree, Masters level modules in dermatology 20 10.8 
Accredited study days (e.g. university or RCN) & or other training (drug company 
study days, conferences) 
104 55.9 
No specialist training 44 23.7 
Number of nurse prescribers (NP) in team  (mean=2.85, median =2.0, mode =1) Yes No  Don’t know 
Do you think there is a need for more NPs in your team? 134(72.0%) 44(23.7%) 7 (3.8%) 
Are there plans to increase the number of NPs in your team? 71 (38.2%) 101 (54.3%) 12(6.5%) 
Are any members of your team currently on the NP course? 35 (18.8%) 146(78.5%) 2 (1.1%) 
Percents do not add to 100%  in each category as some participants did not complete every question 
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Table 2: The number of items prescribed in a typical week for dermatological 
conditions by nurse prescribers by job title 
 
 
 
 Number of items prescribed 
Job Title 0 1-5 6-10 11-20 21-40 >40 Total 
General practice nurses 1 37 24 0 6 4 72 
Specialist and senior nurses 2 36 8 0 0 2 48 
Community Nurses 1 7 1 0 0 0 9 
Higher education & managers 0 2 0 0 0 0 2 
Total 4 82 33 0 6 6 131 
 Kruskal Wallis p<0.001 
 
This table represents the 131 respondents who reported both their job title and number of items prescribed 
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Table 3 Items prescribed by nurse prescribers with training and specialist dermatology 
module 
 
 
 
 
This table represents the 146 respondents who reported both the number of items prescribed per week and 
dermatology training and education 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Items prescribed per week 
 0 1-5 6-10 11-20 >20 
Median 
 (Inter-quartile range)
 
With training ( Without training 
(accredited study days or other 
training (drug company study 
days, conferences))  N=104 1 (1.0%) 48 (46.2%) 30 (28.8%) 15 (14.4%) 10 (9.6%) 
6-10 
(1-5 to 6-10) 
Without training  Without training 
(accredited study days or other 
training (drug company study 
days, conferences))    N=42 2 (4.8%) 32 (76.2%) 4 (9.5%) 3 (7.1%) 1 (2.4%) 
1-5 
(1-5 to 1-5) 
Comparison:  Training  (accredited 
study days or otherwise)       
Mann-Whitney U 
test: P<0.001 
With specialist dermatology 
module  N=18 0 (0.0%) 6 (33.3%) 5 (27.8%) 5 (27.8%) 2 (11.1%) 
6-10 
(1-5 to 11-20) 
Without specialist dermatology 
module  N=128 3 (2.3%) 74 (57.8%) 29 (22.7%) 13 (10.2%) 9 (7.0%) 
1-5 
(1-5 to 6-10) 
Comparison:  Specialist 
dermatology module      
Mann-Whitney U 
test: P=0.18 
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Table 4: The effect of training, job title and care setting on the number of dermatology 
products prescribed at least monthly 
 
 
  
 
(*=Mann- Whitney U Test, **= Kruskal Wallis Test) 
 
This table represents respondents who reported the number of dermatology products prescribed per month and 
provided information about their job title (n=144), care setting (n=146), and dermatology training (n=141) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0 1-5 6-10 11-15 16-22 
Median 
(Inter-
quartile 
range) P value 
General practice nurses (n=88) 1 (1.1%) 9 (10.2%) 31 (35.2%) 39 (44.3%) 8 (9.1%) 10.5 (8-14)  
Specialist & senior clinical nurses (n=45) 4 (8.9%) 13 (28.9%) 20 (44.4%) 7 (15.6%) 1 (2.2%) 2.0 (1-3.5)  
Community (n=9) 0 (0.0%) 5 (55.6%) 4 (44.4%) 0 (0.0%) 0 (0.0%) 3.0 (1-5.75)  
Higher Education /managerial (n=2) 0 (0.0%) 1 (50%) 1 (50%) 0 (0.0) 0 (0.0%) 1.0 (0-1.5)  
Comparison: Job title (n=144) 5 (3.5%) 28 (19.4%) 56 (38.9%) 46 (31.9%) 9 (6.3%)  **P<0.001 
Primary care (n=123) 2 (1.6%) 22 (17.9%) 46 (37.4%) 45 (36.6%) 8 (6.5%) 8.0 (2-12)  
Other  care settings (n=23) 3 (13.0%) 6 (26.1%) 11 (47.8%) 2 (8.7%) 1 (4.3%) 1.1 (0.25-8)  
Comparison: Care setting (n=146) 5 (3.4%) 28 (19.2%) 57 (39.0%) 47 (32.2%) 9 (6.2%)  *P=0.003 
With training  Without training 
(accredited study days or other training 
(drug company study days, 
conferences))   (n=102) 2 (2.0%) 18 (17.6%) 36 (35.3%) 38 (37.3%) 8 (7.8%) 10  (6  to 13)  
Without training (accredited study days 
or other training (drug company study 
days, conferences)) ( n=39) 2 (5.1%) 8 (20.5%) 21 (53.8%) 8 (20.5%) 0 (0.0%) 9  (5  to 10)  
Comparison: Training  (accredited 
study days or otherwise) (n=141)       *P=0.015 
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Table 5: The effect of training, specialist dermatology module, job title and care setting 
on the number of ways the prescribing qualification is used 
 
(*=Mann- Whitney U Test, **= Kruskal Wallis Test) 
 
This table represents respondents who reported the number of ways the prescribing qualification is used and 
information about dermatology training / specialist dermatology module (n=151), job title (n=149), and care 
setting (n=156) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0 1-2 3-5 6-8 
Median 
(Inter-
quartile 
range) P value 
With training (accredited study days or 
other training (drug company study 
days, conferences))  (n=104) 8 (7.7%) 19 (18.3%) 56 (53.8%) 21 (20.2%) 
 
4  (2  to  5)  
Without training (accredited study days 
or other training (drug company study 
days, conferences))  (n=47) 4 (8.5%) 19 (40.4%) 19 (40.4%) 5 (10.7%) 3  (1  to  4)  
Comparison: Training  (accredited 
study days or otherwise) (n=151)      *P=0.002 
With specialist dermatology module 
(n=19) 0 (0.0%) 2 (10.5%) 10 (52.7%) 7 (36.9%) 5  (3  to  6)  
Without specialist dermatology module 
(n=132) 12 (9.1%) 36 (27.3%) 65 (49.3%) 19 (14.4%) 3  (2  to  5)  
Comparison: Specialist dermatology 
module (n=151)      *P=0.007 
General practice nurses (n=93) 7 (7.5%) 22 (23.7%) 44 (47.3%) 20 (21.6%) 4  (2  to  5)  
Specialist & senior clinical nurses 
(n=44) 5 (10.2) 13 (26.5%) 25 (51.0%) 6 (12.2%) 3  (2  to  5)  
Community (n=9) 2 (22.2%) 1 (11.1%) 6 (66.6%) 0 (0.0%) 
3  (0.5  to  
3.5)  
Higher Education /managerial (n=3) 1 (33.3%) 1(33.3%) 1 (33.3%) 0 (0.0%) 1  (0  to  5)  
Comparison: Job title (n=149)      **P=0.105 
Primary care (n=131) 13 (9.9%) 28 (21.4%) 69 (52.6%) 21 (16.1%) 4  (2  to  5)  
Other  care settings (n=25) 2 (8.0%) 10 (40.0%) 8 (32.0%) 5 (20.0%) 3  (1  to  5)  
Comparison: Care setting (n=156)      *P=0.401 
32 
 
Figure 1 
 
 
 
 
 
(General nurses = practice nurses & nurse practitioners; senior clinical nurses= clinical nurse specialists, nurses consultants, 
modern matrons, mental health nurse; Community = community matron, health visitor, district nurses, school nurse; 
HE/managers= Higher education and managers) 
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Figure2 
 
 
 
GP = General Practitioner, FP10 = a prescription form purchased by a trust for prescribing medication that is to 
be dispensed by community pharmacies in the UK 
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